Skip to Content

Pineapple Inc PNPL

Morningstar Rating
$0.06 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PNPL is trading at a 49% discount.
Price
$0.06
Fair Value
$2.98
Uncertainty
Extreme
1-Star Price
$4.59
5-Star Price
$7.70
Economic Moat
Gnvq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PNPL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.06
Day Range
$0.060.06
52-Week Range
$0.021.80
Bid/Ask
$0.06 / $0.14
Market Cap
$4.39 Mil
Volume/Avg
100 / 1,306

Key Statistics

Price/Earnings (Normalized)
8.36
Price/Sales
29.32
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pineapple Inc Formerly Pineapple Express Inc through its subsidiary provides expert consulting, product licensing, and capital to help distinguish and grow new and existing businesses within the cannabis industry. Primarily the group is involved in purchase and lease of real estate property, offering consulting services and technology to develop and enhance canna-businesses. It derives most of the revenue from of rent and tent reimbursements source.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Total Number of Employees

Valuation

Metric
PNPL
Price/Earnings (Normalized)
8.36
Price/Book Value
Price/Sales
29.32
Price/Cash Flow
Price/Earnings
PNPL

Financial Strength

Metric
PNPL
Quick Ratio
Current Ratio
0.00
Interest Coverage
Quick Ratio
PNPL

Profitability

Metric
PNPL
Return on Assets (Normalized)
−28.25%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−51.74%
Return on Assets
PNPL
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncRdtyzzdrFyxsc$15.7 Bil
RADLY
Raia Drogasil SA ADRXhmyzb$8.4 Bil
ALBHF
Alibaba Health Information Technology LtdFwprcvy$5.5 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRLzfqh$5.5 Bil
CLCGY
Clicks Group Ltd ADRVzrchw$3.6 Bil
TSUSF
Tsuruha Holdings IncRtqzxmb$3.1 Bil
SGIPF
Sugi Holdings Co LtdVcgg$2.8 Bil
SAEYY
Redcare Pharmacy NV ADRKtv$2.6 Bil
SHPPF
Redcare Pharmacy NVLngz$2.6 Bil
ZRSEF
DocMorris AGYyrp$1.1 Bil

Sponsor Center